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We have previously reported that radon inhalation activates anti-oxidative functions and inhibits carbon
tetrachloride (CCl4)-induced hepatopathy. It has also been reported that antioxidant vitamins can inhibit
CCl4-induced hepatopathy. In the current study, we examined the comparative efficacy of treatment with
radon, ascorbic acid and α-tocopherol on CCl4-induced hepatopathy. Mice were subjected to intraperitoneal
injection of CCl4 after inhaling approximately 1000 or 2000 Bq/m
3 radon for 24 h, or immediately after
intraperitoneal injection of ascorbic acid (100, 300, or 500 mg/kg bodyweight) or α-tocopherol (100, 300,
or 500 mg/kg bodyweight). We estimated the inhibitory effects on CCl4-induced hepatopathy based on
hepatic function-associated parameters, oxidative damage-associated parameters and histological changes.
The results revealed that the therapeutic effects of radon inhalation were almost equivalent to treatment with
ascorbic acid at a dose of 500 mg/kg or α-tocopherol at a dose of 300 mg/kg. The activities of superoxide
dismutase, catalase, and glutathione peroxidase in the liver were significantly higher in mice exposed
to radon than in mice treated with CCl4 alone. These findings suggest that radon inhalation has an anti-
oxidative effect against CCl4-induced hepatopathy similar to the anti-oxidative effects of ascorbic acid or
α-tocopherol due to the induction of anti-oxidative functions.
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INTRODUCTION
Carbon tetrachloride (CCl4) is a well-established hepato-
toxin, producing free radicals during its metabolism in the
liver [1–2]. Overproduction of these radicals initiates lipid
peroxidation of polyunsaturated fatty acids in the cell mem-
brane and eventually leads to cell death by necrosis.
Ascorbic acid (AA; vitamin C), a well-known antioxidant,
is a water-soluble vitamin that can protect against damage
induced by reactive oxygen species (ROS) or free radicals.
It has been reported that AA protects against cellular
damage from lipid peroxide-derived 2-alkenals [3]. A
recent study suggested that AA treatment reduces
CCl4-induced oxidative damage in the liver, and that AA
has a highly protective effect against hepatotoxicity and
oxidative stress caused by CCl4 [4]. α-Tocopherol (vitamin
E) is another antioxidant vitamin and is lipid-soluble. A
previous report indicated that vitamin E protects against
CCl4-induced chronic liver damage [5].
Low-dose irradiation induces various stimulus effects,
such as activation of anti-oxidative factors [6–11].
Low-dose X- or γ-irradiation activates anti-oxidative func-
tions in some organs [12–13]. For example, low-dose
X-irradiation inhibits brain edema induced by cold injury
[12] and paw edema induced by ischemia-reperfusion
injury [13]. These findings indicate that low-dose irradi-
ation has anti-oxidative effects and inhibits oxidative
damage in certain organs.
Therapy involving radon gas volatilized from radon-
enriched water is performed for various diseases at Misasa
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Medical Center, Okayama University Hospital. Most condi-
tions treated with radon therapy are lifestyle-related diseases
such as arteriosclerosis, osteoarthritis [14] and bronchial
asthma [15]. In addition, a large number of patients are
treated in various countries with traditional spa therapy
(Japan [14–16], central Europe [17]). To assess the effects
of radon, we have developed a radon-exposure system for
small animals; using this system, we demonstrated that
radon inhalation has anti-inflammatory effects and inhibits
carrageenan-induced inflammatory paw edema [18]. We
also demonstrated that radon inhalation inhibits the oxida-
tive damage associated with CCl4-induced hepatopathy in
mice, indicating that radon inhalation has anti-oxidative
effects [19]. It is highly possible that radon inhalation acts
by preventing or reducing ROS-related injuries. These find-
ings also suggest that radon inhalation has anti-oxidative
effects similar to X-irradiation.
Recently, in a search for new indications for radon
therapy, we reported the responsiveness of superoxide dis-
mutase (SOD) in mouse organs to radon [20]. In that study,
we examined the changes in SOD activity in many mouse
organs, including plasma, brain, lung, thymus, heart, liver,
stomach, pancreas, kidney and small intestine. The results
suggest that radon inhalation increases SOD activities in
most organs; however, to date there have been no quantita-
tive reports on the anti-oxidative effects of radon so the
optimal conditions for radon therapy remain undetermined.
The purpose of this study was to compare the anti-oxidative
effects of radon and antioxidant vitamins such as AA and
α-tocopherol. To assess the anti-oxidative effects of radon,
we used a CCl4 -induced liver injury model. The following
biochemical and histological parameters were examined to
assess the anti-oxidative effects of radon: SOD activity,
catalase activity, glutathione peroxidase (GPx) activity,
total glutathione content (t-GSH), lipid peroxide levels and
triglyceride levels (TG) in the liver; glutamic oxaloacetic
transaminase (GOT) and glutamic pyruvic transaminase
(GPT) activity, TG and total cholesterol (T-CHO) levels in
the serum; and histological examination of liver tissue.
MATERIALS AND METHODS
Animals
Female ICR mice (aged 8 weeks, body weight approxi-
mately 28 g) were obtained from Charles River
Laboratories Japan Inc. (Yokohama, Japan). Ethics approv-
al for all protocols and experiments was obtained from the
Animal Experimental Committee of Okayama University.
Mice inhaled radon at a concentration of 1000 or 2000 Bq/
m3 for 24 h. The radon concentration in the mouse cage
was measured using a radon monitor (CMR-510;
femto-Tech Inc., OH, USA). Mice had free access to food
and water during radon inhalation and sham treatment.
Then, 4 ml/kg bodyweight of CCl4 (5% in olive oil; Wako
Pure Chemical Industries, Ltd., Osaka, Japan) was injected
into the peritoneum of the mice immediately after radon in-
halation or immediately after intraperitoneal (i.p.) injection
of L(+)-ascorbic acid (100, 300 or 500 mg/kg weight;
Kanto Chemical Co. Inc., Tokyo, Japan) or DL-α-
tocopherol (100, 300 or 500 mg/kg weight; Nacalai Tesque
Inc., Kyoto, Japan). Twenty-four hours after CCl4 adminis-
tration, blood was drawn from the heart for serum analysis,
and livers were quickly excised to analyze the levels of
SOD, catalase, t-GSH, GPx, TG and lipid peroxide. Serum
was separated by centrifugation at 3000 × g for 5 min for the
assay of GOT and GPT activity, and the TG and T-CHO
levels. These samples were preserved at –80°C until the bio-
chemical assay. Liver tissue samples were fixed in 10%
neutral-buffered formalin for histological examinations.
Biochemical assays
The serum activity of GOT and GPT, serum levels of TG
and T-CHO, and the levels of TG in liver were measured
using TA-LN, TG-EN and T-CHO kainosu, respectively
(Kainosu Co., Ltd., Tokyo, Japan) according to the manu-
facturer’s recommendations.
Mouse livers were homogenized on ice in 10 mM
phosphate-buffered saline (PBS; pH 7.4). The homogenates
were centrifuged at 12 000 × g for 45 min at 4°C and the
supernatants were used to assay the activity of SOD and
catalase.
SOD activity was measured by the nitroblue tetrazolium
(NBT) reduction method [21] using the Wako-SOD test
(Wako Pure Chemical Industry, Co., Ltd., Osaka, Japan)
according to the manufacturer’s recommendations. Briefly,
the extent of inhibition of the reduction in NBT was mea-
sured at 560 nm using a spectrophotometer. One unit of
enzyme activity was defined as 50% inhibition of NBT
reduction.
Catalase activity was measured as the rate of hydrogen
peroxide (H2O2) reduction at 37°C at 240 nm wavelength
[22]. The assay mixture consisted of 50 µl 1 M Tris-HCl
buffer containing 5 mM ethylenediaminetetraacetic acid
(pH 7.4), 900 µl 10 mM H2O2, 30 µl deionized water, and
20 µl liver supernatant. Activity was calculated using a
molar extinction coefficient of 7.1 × 10−3 M−1cm−1.
Total glutathione content was measured using the
Bioxytech GSH-420 assay kit (Oxis Health Products, Inc.,
Portland, OR, USA) according to the manufacturer’s
recommendations. This assay is based on the formation of
a chromophoric thione, whose absorbance at 420 nm is dir-
ectly proportional to the total glutathione concentration.
Briefly, liver samples were suspended in 10 mM PBS (pH
7.4), mixed with ice-cold 7.5% trichloroacetic acid solution
and homogenized. The homogenates were centrifuged at
3000 × g for 10 min. The supernatants were used for the
assay.
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Lipid peroxide levels were assayed using the Bioxytech
LPO-586 assay kit (Oxis Health Products, Inc.) according
to the manufacturer’s recommendations. The lipid peroxide
assay is based on the reaction between a chromogenic
reagent, N-methyl-2-phenylidole, and malondialdehyde and
4-hydroxyalkenals at 45°C. Data are derived from the
optical density of the colored products at 586 nm. Briefly,
liver samples were homogenized in 10 mM PBS (pH 7.4)
on ice. Prior to homogenization, 10 µL of 0.5 M butylated
hydroxytoluene in acetonitrile was added per 1 mL buffer-
tissue mixture. After homogenization, the homogenate was
centrifuged at 15 000 × g for 10 min at 4°C, and the super-
natant was used for the assay.
GPx activity was measured using the BIOXYTECH
GPx-340 assay kit (Oxis Health Products, Inc.) according
to the manufacturer’s recommendations. Briefly, liver
samples were homogenized in 1 M Tris–HCl buffer (pH
7.4) containing 5 mM ethylenediaminetetraacetic acid and
1 mM dithiothreitol. Homogenates were centrifuged at 10
000 × g for 20 min at 4°C. The supernatants were used for
the assay. The reduction of nicotinamide adenine dinucleo-
tide phosphate (NADPH) to nicotinamide adenine dinucleo-
tide phosphate (NADP+) is accompanied by a decrease in
absorbance at 340 nm based on which GPx enzyme activity
is calculated. The molar extinction coefficient for NADPH
is 6220 M−1 cm−1 at 340 nm. To assay GPx levels, the
supernatant is added to a solution containing glutathione,
glutathione reductase (GR) and NADPH. The enzyme reac-
tion is initiated by adding the substrate, tert-butyl hydroper-
oxide, and absorbance at 340 nm is recorded for 3 min.
The protein content in each sample was measured by the
Bradford method, using the Protein Quantification Kit-Rapid
(Dojindo Molecular Technologies, Inc., Kumamoto, Japan),
as described previously [23].
Histological examination
Liver samples were fixed in 10% formalin, processed
through a graded ethanol series and finally xylene, and em-
bedded in paraffin. Six-micrometer-thick tissue sections
were prepared and stained with hematoxylin-eosin (HE).
Inhibition score
We defined the inhibition rate (%) of GOT, GPT, TG,
T-CHO, lipid peroxide level and histology by the following
formula:
Inhibition Rate (%) ¼
100
ðmean value of vitamin treated or radon inhaled groupsÞ
ðmean value of control groupÞ
ðmean value of CCl4 administrated groupÞ






To compare the inhibitory effects, the baseline clinical
score was determined according to the inhibition rate.
Briefly, no inhibitory effect (<10%) was scored as 0; inhib-
ition rate of 10% to 40% from baseline was scored as 1;
40% to 70% was scored as 2; and >70% was scored as 3.
Statistical analyses
Data are presented as the mean ± standard error of the mean
(SEM). Each experimental group consisted of samples from
5–8 animals. The statistical significance of differences was
determined by Student’s t-test for comparisons between the
control group the and CCl4-administered group. Dunnett’s
test was used for multiple comparisons.
RESULTS
Changes in the radon concentration
Radon concentrations in the mouse cages are shown in
Fig. 1. The mean concentrations of treatment radon were
approximately 1000 Bq/m3 and 2000 Bq/m3, respectively
(Fig. 1).
Effects of AA, α-tocopherol or radon on hepatic
function following CCl4 administration
The effects of CCl4 administration on hepatic function in
mice pretreated with AA, α-tocopherol or radon were exam-
ined. In mice injected with CCl4 in the absence of AA,
α-tocopherol or radon pretreatment, the activities of GOT
and GPT in serum were significantly higher (P < 0.001) and
the TG level in serum was significantly lower (P < 0.001)
than in control animals. However, GOT activities in the
serum of AA- (300 or 500 mg/kg weight, P < 0.05 and P <
0.01, respectively), α-tocopherol- (300 or 500 mg/kg weight,
P < 0.05 and P < 0.001, respectively) and radon- (2000 Bq/
m3, P < 0.05) treated mice, and GPT activities in the serum
of AA- (300 or 500 mg/kg weight, P < 0.05), α-tocopherol-
(500 mg/kg weight, P < 0.01) and radon- (2000 Bq/m3, P <
0.05) treated mice were significantly lower than those of
CCl4-administered mice. The activities of GOT and GPT in
the serum of other groups tended to be lower than those of
Fig. 1. Changes in radon concentration in mouse cages over the
period of radon inhalation using a radon-exposure system.
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CCl4-administered mice, but these differences were not statis-
tically significant. In the absence of AA, α-tocopherol or
radon pretreatment, the T-CHO levels in the serum of
CCl4-administered mice were lower than in control animals,
but those differences were not statistically significant. T-CHO
levels in the serum of α-tocopherol- (300 mg/kg weight)
treated mice were significantly higher (P < 0.05) than in
CCl4-administered mice; however, there were no significant
differences in TG levels between CCl4-administered mice and
mice treated with AA, α-tocopherol or radon (Fig. 2).
Effects of AA, α-tocopherol or radon on TG level
in liver following CCl4 administration
The effects of CCl4 administration on TG accumulation in
the liver of mice pretreated with AA, α-tocopherol or radon
were examined. In mice injected with CCl4 in the absence
of AA, α-tocopherol or radon pretreatment, TG levels in the
liver were significantly higher (P < 0.001) than in control
animals; however, TG levels in the liver of α-tocopherol-
(300 or 500 mg/kg weight, P < 0.001) or radon- (2000 Bq/
m3, P < 0.05) treated mice were significantly lower than in
Fig. 2. Effects of AA, α-tocopherol and radon on hepatic function-associated parameters in the serum of CCl4-administered mice. Each
value is the mean ± SEM. The number of mice per experimental point is 5–8. *P < 0.05, **P < 0.01, ***P < 0.001 vs CCl4 in the absence
of AA, α-tocopherol or radon, ###P < 0.001 vs Control.
Comparative study of antioxidant vitamins and radon 833
CCl4-administered mice. TG levels in the liver of other
groups tended to be lower than those in the CCl4-administered
group, but those differences were not statistically significant
(Fig. 3).
Effects of AA, α-tocopherol or radon on
hepatocytes
CCl4 administration resulted in centrilobular necrosis of the
liver. Necrosis in the CCl4 group tended to be greater than
in groups pretreated with AA, α-tocopherol or radon, but
these differences were not statistically significant. In con-
trast, no centrilobular necrosis was observed in control
animals (Fig. 4).
Effects of AA, α-tocopherol and radon on lipid
peroxide levels in liver following CCl4
administration
The effects of CCl4 administration on lipid peroxide levels
in the liver of mice pretreated with AA, α-tocopherol and
radon were examined. In mice injected with CCl4 in the
absence of AA, α-tocopherol, or radon pretreatment, lipid per-
oxide levels in the liver were significantly higher (P < 0.05)
than in control animals. However, the lipid peroxide levels
in the liver of AA- (500 mg/kg weight, P < 0.01) or α-
tocopherol- (300 or 500 mg/kg weight, P< 0.05 and P< 0.01,
respectively) treated mice were significantly lower than in
CCl4-administered mice. The lipid peroxide levels in the
liver of other groups tended to be lower than in the CCl4-
administered group, but these differences were not statistically
significant (Fig. 5).
Inhibition ratio of CCl4-induced hepatopathy
We scored the inhibition rate of CCl4-induced hepatopathy
as shown in Materials and Methods. The score of
AA-treated mice at a dose of 100, 300 and 500 mg/kg
bodyweight was 0.9 ± 0.1, 1.3 ± 0.4 and 1.4 ± 0.3, respect-
ively. The score of α-tocopherol-treated mice at a dose of
100, 300 and 500 mg/kg bodyweight was 0.7 ± 0.3, 1.4 ±
0.5 and 1.6 ± 0.4, respectively.
In addition, the score of mice which had inhaled radon at
a concentration of 1000 or 2000 Bq/m3 was 1.4 ± 0.3 and
1.4 ± 0.2, respectively. The score depended on the dosage
of AA or α-tocopherol; however, no dose dependency was
observed in mice which had inhaled radon. In summary,
treatment with AA, α-tocopherol and radon inhibited lipid
peroxidation induced by CCl4 (Table 1).
Effects of AA, α-tocopherol and radon on
antioxidant-associated substances in liver following
CCl4 administration
The effects of CCl4 administration on antioxidant-associated
substances in the liver of mice pretreated with AA,
α-tocopherol or radon were examined. In mice injected with
CCl4 in the absence of AA, α-tocopherol or radon pretreat-
ment, the activities of SOD (P < 0.05), catalase (P < 0.001),
GPx (P < 0.01) and t-GSH content (P < 0.05) in the liver
were significantly lower than in control animals. However,
the activities of SOD and catalase (1000 Bq/m3 or 2000
Bq/m3, SOD; P < 0.05, catalase; P < 0.01 and P < 0.001, re-
spectively) in the liver of mice which had inhaled radon
and GPx activity (2,000 Bq/m3, P < 0.01) in the liver of
mice which had inhaled radon were significantly higher in
CCl4-administered mice. In addition, treatment with AA
(100, 300, or 500 mg/kg weight) or α-tocopherol (100,
300, or 500 mg/kg weight) did not result in an increase in
SOD, catalase, GPx or t-GSH in the liver (Fig. 6).
DISCUSSION
We previously reported that 0.5 Gy X-irradiation or radon
inhalation activated anti-oxidative function in the liver and
inhibited oxidative damage in mice. For example, pretreat-
ment with low-dose X-irradiation inhibits CCl4-induced
hepatopathy [24–26] and post-treatment low-dose
X-irradiation reduced the oxidative damage associated with
CCl4-induced hepatopathy [27]. It appears to be highly
likely that low-dose irradiation, including radon inhalation,
helps to prevent or reduce ROS-related liver damage [26].
Fig. 3. Effects of AA, α-tocopherol and radon on TG levels in the liver of CCl4-administered mice. Each value is the mean ± SEM. The
number of mice per experimental point is 7–8. *P < 0.05, ***P < 0.001 vs CCl4 in the absence of AA, α-tocopherol or radon,
###P < 0.001
vs Control.
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Therefore, we used a model of liver injury in mice to quan-
titatively compare the anti-oxidative effects of radon inhal-
ation and antioxidant vitamins.
AA and α-tocopherol are well-known antioxidants, easily
obtained from foods or supplements. AA is soluble in
water, scavenging ROS in the aqueous phase. In contrast,
Fig. 4. Effects of AA, α-tocopherol and radon on CCl4-induced hepatopathy in mice. Mouse livers were examined histologically. A
Control; B CCl4 administration; C 300 mg/kg weight of AA treatment + CCl4 administration; D 300 mg/kg weight of α-tocopherol
treatment + CCl4 administration; E 2000 Bq/m
3 of radon inhalation + CCl4 administration. Scale bar represents 250 µm. All samples were
stained with HE. The area of cell necrosis surrounding the central vein (cv), but not portal vein (pv), in the CCl4-administered mice was
measured; F Area of damage was less in mice pretreated with AA, α-tocopherol or radon relative to those treated with only CCl4. No
centrilobular necrosis was observed in control animals (ND = not detectable). Each value is the mean ± SEM. The number of mice per
experimental point was 5–8.
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α-tocopherol is a lipophilic antioxidant, so it scavenges
ROS in the membrane [28]. Radon has both hydro-soluble
and lipophilic radioisotopes; therefore, to elucidate the effects
of radon in detail, it is very instructive to compare the antiox-
idative effects between radon and these two vitamins.
AA reacts readily with superoxide anions and hydrogen
peroxide [29], and α-tocopherol has the ability to scavenge
peroxyl radicals [3]. Moreover, it is reported that both AA
and α-tocopherol are absorbed quickly (within several
hours) [30–31]. In one study the AA concentration in the
liver of AA-deficient mice peaked 3 hours after AA intake
and then decreased [30]. Another report suggested that
α-tocopherol in the liver peaked at around 1 hour and then
decreased [31]. Although there are differences in the experi-
mental conditions between these studies, they suggest that
AA and α-tocopherol are absorbed quickly after administra-
tion and increase antioxidant activity in the liver.
SOD activity catalyzes the conversion of superoxide
anions into H2O2, and catalase transforms hydrogen
peroxide into H2O. GSH reacts directly with ROS, and
GPx catalyzes the destruction of H2O2 and hydroxyl radi-
cals [32]. This catalysis generates GSSG and finally GSH;
however, GR catalyzes the regeneration of GSH from
GSSG. Thus, GR and GPx are both enzymes in the
generating GSH pathway, and AA plays the same role as
antioxidant enzymes. It has been reported that GSH protects
against CCl4-induced microsomal lipid peroxidation [33]
and can scavenge trichloromethyl peroxyl radicals but not
trichloromethyl radicals [34]. In fact, low-dose irradiation,
including radon inhalation, increases t-GSH content in the
liver and reduces oxidative damage [24–25]. In addition, AA
treatment reduces oxidative damage in the liver [34–35].
The results of this study show that CCl4 administration
significantly increases the activities of GOT and GPT and
the levels of lipid peroxide and TG in the liver. These find-
ings indicate that CCl4 administration depresses hepatic
function and induces oxidation and fatty liver. In addition,
CCl4 results in centrilobular necrosis; therefore, we compre-
hensively examined the inhibitory effects of radon inhal-
ation and treatment with antioxidant vitamins on
CCl4-induced hepatopathy using hepatic function-associated
and oxidative damage-associated parameters, and observa-
tion of histological changes. Treatment with AA or
α-tocopherol reduced the activities of GOT and GPT in
serum, and the levels of TG and lipid peroxide in the liver
of CCl4-administered mice. This inhibitory effect depended
on the dosage of AA or α-tocopherol. Radon inhalation at
a concentration of 2000 Bq/m3 also decreased the activities
of GOT and GPT in serum. These findings suggest that
treatment with AA, α-tocopherol or radon can inhibit
CCl4-induced hepatopathy. In addition, TG levels in the
liver of mice treated with α-tocopherol or radon were sig-
nificantly decreased in CCl4-administered mice. These
results suggest that treatment with α-tocopherol or radon
inhibits CCl4-induced fatty liver. Furthermore, AA treat-
ment at a dose of 500 mg/kg weight, or α-tocopherol treat-
ment at a dose of 300 or 500 mg/kg weight, significantly
reduced the lipid peroxide level in the liver, suggesting that
Fig. 5. Effects of AA, α-tocopherol and radon on lipid peroxide levels in the liver of CCl4-administered mice. Each value is the mean ±
SEM. The number of mice per experimental point is 6–8. *P < 0.05, **P < 0.01 vs CCl4 in the absence of AA, α-tocopherol or radon,
#P < 0.05 vs Control.
Table 1. Inhibitory effects of AA, α-tocopherol and radon







100 300 500 100 300 500 1000 2000
GOT 1 2 2 0 1 2 1 2
GPT 1 1 1 0 1 1 1 1
T-CHO 1 1 1 1 2 1 3 1
TG (serum) 0 0 1 0 0 0 1 1
TG (liver) 1 1 1 1 3 3 1 2
Lipid peroxide 1 3 3 2 3 3 2 2
Histological score 1 1 1 1 0 1 1 1
Average 0.9 1.3 1.4 0.7 1.4 1.6 1.4 1.4
SEM 0.1 0.4 0.3 0.3 0.5 0.4 0.3 0.2
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treatment of antioxidant vitamin such as AA or α-tocoph-
erol inhibits oxidation induced by CCl4.
The inhibition rate of CCl4-induced hepatopathy increased
with the dosage of AA (R2 = 0.932, R: correlation coefficient)
or α-tocopherol (R2 = 0.871). It seems that the inhibition rate
correlates with the vitamin concentration; however, no dose
dependency was observed in radon-inhaled groups. According
to these results, radon inhalation has an anti-oxidative effect
similar to AA treatment at a dose of 500 mg/kg bodyweight,
or α-tocopherol at 300 mg/kg bodyweight.
To clarify the mechanisms underlying the inhibitory
effect of radon inhalation, we examined antioxidant-
associated substances such as SOD, catalase, t-GSH and
GPx. Our previous study suggested that radon inhalation at
a concentration of 2000 Bq/m3 significantly increased the
activities of GPx activity and t-GSH content in mouse liver
[19]. In addition, another report suggested that radon inhal-
ation at a concentration of 1000 Bq/m3 significantly
increased SOD activity in the liver of BALB/c mice, which
are sensitive to radiation [20]. These findings suggest that
Fig. 6. Effects of AA, α-tocopherol and radon on anti-oxidative-associated parameters in the liver of CCl4-administered mice. Each
value is the mean ± SEM. The number of mice per experimental point is 6–8. *P < 0.05, **P < 0.01, ***P < 0.001 vs CCl4 in the absence
of AA, α-tocopherol or radon, #P < 0.05 ##P < 0.01, ###P < 0.001 vs Control.
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radon inhalation activates antioxidative functions in mouse
liver. In this study, the activity levels of SOD, catalase and
GPx in the livers of mice which had inhaled radon were
significantly higher than in those of CCl4-treated mice;
however, there were no significant differences in the
activity levels of SOD, catalase and GPx, and in t-GSH
content in livers between the CCl4-administered group and
the AA- or α-tocopherol-treated groups. No dose depend-
ency was observed in the increase of antioxidative-
associated parameters in the livers of radon-inhaled groups;
therefore, no dose dependency may be observed in the
scores.
Our radon exposure system is effective in terms of
keeping low radon progeny in the mouse cage. The equilib-
rium equivalent radon concentration, the radon progeny
concentration, was quite low compared with the concentra-
tion of the coexisting radon, even if the air balance in the
mouse cage was considered, because air was supplied
through a HEPA filter [36]. According to Sakoda’s report
[37], the dose absorbed by the lung was 75 to 150 nGy
under their experimental conditions. In addition, the dose
absorbed by the liver was almost the same as the lung. The
absorbed doses were 500 to 1000 times larger than
the background level; however, it is difficult to estimate
the dose absorbed by the whole body because there are no
reports of these models in mice.
Since the 2011 nuclear accident in Fukushima, the
effects of low-dose irradiation are at the forefront of
the public’s attention. There have been many reports of the
stimulatory effects of low-dose irradiation; however, there
have been no quantitative reports concerning the anti-
oxidative effects induced by low-dose irradiation. It is diffi-
cult to explain the effects of low-dose irradiation in terms
that the public can readily understand; therefore, this report
might provide a useful example of the effects of low-dose
irradiation in relation to vitamins common in our daily lives.
CONCLUSION
In conclusion, radon inhalation has an anti-oxidative effect
against CCl4-induced hepatopathy that is comparable to
treatment with AA at a dose of 500 mg/kg weight or
α-tocopherol treatment at a dose of 300 mg/kg weight, due
to activation of anti-oxidative functions. Radon therapy is
performed for various diseases at Misasa Medical Center,
Okayama University Hospital. No previous reports on the
quantitative effects of radon therapy have been reported,
however, quantitative evaluation of the activation of anti-
oxidative functions after radon inhalation will provide a
basis for future studies aimed at assessing new radon-based
therapies. In addition, further study on the therapeutic
effects of a combination of radon and AA on liver diseases
is warranted.
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